Genetic polymorphisms of TERT and CLPTM1L and risk of lung cancer: A case-control study in northeast Chinese male population

Medical Oncology

Volumn 31, Issue 7, 2014, Pages

  Zhang, Yue ^a,b   Zhao, Mengmeng ^a,b   Shen, Li ^a,b   Ren, Yangwu ^a,b   Su, Lingyan ^a,b   Li, Xuelian ^a,b   Yin, Zhihua ^a,b   Zhou, Baosen ^a,b  

^a CHINA MEDICAL UNIVERSITY   (China)

^b University of Liaoning Province   (China)

Author keywords

CLPTM1L; Lung cancer; Males; Polymorphisms; TERT

Indexed keywords

TELOMERASE REVERSE TRANSCRIPTASE; CLPTM1L PROTEIN, HUMAN; MEMBRANE PROTEIN; TELOMERASE; TERT PROTEIN, HUMAN; TUMOR PROTEIN;

ADULT; ALLELE; ARTICLE; CANCER RISK; CHINESE; CLEFT LIP AND PALATE TRANSMEMBRANE 1 LIKE GENE; CONTROLLED STUDY; DNA POLYMORPHISM; ENVIRONMENTAL EXPOSURE; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; SMOKING; TUMOR GENE; ADENOCARCINOMA; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; LUNG TUMOR; MIDDLE AGED; POPULATION GENETICS; RISK; SINGLE NUCLEOTIDE POLYMORPHISM; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; HUMANS; LUNG NEOPLASMS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; TELOMERASE;

EID: 84901583415     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-014-0018-4     Document Type: Article

References (39)

1. Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893-917.
2. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69-90.
3. Alberg AJ, Samet JM. Epidemiology of lung cancer. Chest. 2003;123:21S-49S. (Pubitemid 36135701)
4. Wang Y, Broderick P, Webb E, et al. Common 5p15.33 and 6p21.33 variants influence lung cancer risk. Nat Genet. 2008;40:1407-9.
5. Broderick P, Wang Y, Vijayakrishnan J, et al. Deciphering the impact of common genetic variation on lung cancer risk: a genome-wide association study. Cancer Res. 2009;69:6633-41.
6. Hu Z, Wu C, Shi Y, et al. A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese. Nat Genet. 2011;43:792-6.
7. Landi MT, Chatterjee N, Yu K, et al. A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am J Hum Genet. 2009;85:679-91.
8. McKay JD, Hung RJ, Gaborieau V, et al. Lung cancer susceptibility locus at 5p15.33. Nat Genet. 2008;40:1404-6.
9. Rafnar T, Sulem P, Stacey SN, et al. Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nat Genet. 2009;41:221-7.
10. Sambrook J. Molecular Cloning: A Laboratory Manual. New York: Cold Spring Harbor Laboratory Press; 1989.
11. Livak KJ. Allelic discrimination using fluorogenic probes and the 5′ nuclease assay. Genet Anal. 1999;14:143-9. (Pubitemid 29095371)
12. Choi JE, Kang HG, Jang JS, et al. Polymorphisms in telomere maintenance genes and risk of lung cancer. Cancer Epidemiol Biomarkers Prev. 2009;18:2773-81.
13. Li C, Yin Z, Wu W, et al. Genetic variations in TERT-CLPTM1L genes and risk of lung cancer in Chinese women nonsmokers. PLoS ONE. 2013;8:e64988.
14. Wick M, Zubov D, Hagen G. Genomic organization and promoter characterization of the gene encoding the human telomerase reverse transcriptase (hTERT). Gene. 1999;232:97-106. (Pubitemid 29305322)
15. Miller RA. Telomere diminution as a cause of immune failure in old age: an unfashionable demurral. Biochem Soc Trans. 2000;28:241-5. (Pubitemid 30103249)
16. Damjanovic AK, Yang Y, Glaser R, et al. Accelerated telomere erosion is associated with a declining immune function of caregivers of Alzheimer's disease patients. J Immunol. 2007;179:4249-54.
17. Collins K, Mitchell JR. Telomerase in the human organism. Oncogene. 2002;21:564-79. (Pubitemid 34146256)
18. Bagheri S, Nosrati M, Li S, et al. Genes and pathways downstream of telomerase in melanoma metastasis. Proc Natl Acad Sci U S A. 2006;103:11306-11. (Pubitemid 44156513)
19. Jang JS, Choi YY, Lee WK, et al. Telomere length and the risk of lung cancer. Cancer Sci. 2008;99:1385-9. (Pubitemid 351761728)
20. Kyo S, Inoue M. Complex regulatory mechanisms of telomerase activity in normal and cancer cells: how can we apply them for cancer therapy? Oncogene. 2002;21:688-97. (Pubitemid 34146272)
21. Chen H, Chen Y, Zhao Y, et al. Association of sequence variants on chromosomes 20, 11, and 5 (20q13.33, 11q23.3, and 5p15.33) with glioma susceptibility in a Chinese population. Am J Epidemiol. 2011;173:915-22.
22. Ding CY, Hu LM, Hu ZB, et al. The relationship between gene polymorphism of telomerase reverse transcriptase and susceptibility to hepatocellular carcinoma. Zhonghua Yu Fang Yi Xue Za Zhi. 2011;45:593-6.
23. Gago-Dominguez M, Jiang X, Conti DV, et al. Genetic variations on chromosomes 5p15 and 15q25 and bladder cancer risk: findings from the Los Angeles-Shanghai bladder case-control study. Carcinogenesis. 2011;32:197-202.
24. Hofer P, Baierl A, Bernhart K, et al. Association of genetic variants of human telomerase with colorectal polyps and colorectal cancer risk. Mol Carcinog. 2012;51:E176-82.
25. Liu Z, Li G, Wei S, et al. Genetic variations in TERT-CLPTM1L genes and risk of squamous cell carcinoma of the head and neck. Carcinogenesis. 2010;31:1977-81.
26. Savage SA, Chanock SJ, Lissowska J, et al. Genetic variation in five genes important in telomere biology and risk for breast cancer. Br J Cancer. 2007;97:832-6. (Pubitemid 47396285)
27. Wang S, Wu J, Hu L, et al. Common genetic variants in TERT contribute to risk of cervical cancer in a Chinese population. Mol Carcinog. 2012;51:E118-22.
28. Yamamoto K, Okamoto A, Isonishi S, et al. A novel gene, CRR9, which was up-regulated in CDDP-resistant ovarian tumor cell line, was associated with apoptosis. Biochem Biophys Res Commun. 2001;280:1148-54. (Pubitemid 32924460)
29. Zienolddiny S, Skaug V, Landvik NE, et al. The TERT-CLPTM1L lung cancer susceptibility variant associates with higher DNA adduct formation in the lung. Carcinogenesis. 2009;30:1368-71.
30. Kohno T, Kunitoh H, Shimada Y, et al. Individuals susceptible to lung adenocarcinoma defined by combined HLA-DQA1 and TERT genotypes. Carcinogenesis. 2010;31:834-41.
31. Miki D, Kubo M, Takahashi A, et al. Variation in TP63 is associated with lung adenocarcinoma susceptibility in Japanese and Korean populations. Nat Genet. 2010;42:893-6.
32. Petersen GM, Amundadottir L, Fuchs CS, et al. A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet. 2010;42:224-8.
33. Pooley KA, Tyrer J, Shah M, et al. No association between TERT-CLPTM1L single nucleotide polymorphism rs401681 and mean telomere length or cancer risk. Cancer Epidemiol Biomarkers Prev. 2010;19:1862-5.
34. Yoon KA, Park JH, Han J, et al. A genome-wide association study reveals susceptibility variants for non-small cell lung cancer in the Korean population. Hum Mol Genet. 2010;19:4948-54.
35. Kanetsky PA, Mitra N, Vardhanabhuti S, et al. A second independent locus within DMRT1 is associated with testicular germ cell tumor susceptibility. Hum Mol Genet. 2011;20:3109-17.
36. Pande M, Spitz MR, Wu X, et al. Novel genetic variants in the chromosome 5p15.33 region associate with lung cancer risk. Carcinogenesis. 2011;32:1493-9.
37. Bae EY, Lee SY, Kang BK, et al. Replication of results of genome-wide association studies on lung cancer susceptibility loci in a Korean population. Respirology. 2012;17:699-706.
38. Chen XF, Cai S, Chen QG, et al. Multiple variants of TERT and CLPTM1L constitute risk factors for lung adenocarcinoma. Genet Mol Res. 2012;11:370-8.
39. Myneni AA, Chang SC, Niu R, et al. Genetic polymorphisms of TERT and CLPTM1L and risk of lung cancer - a case-control study in a Chinese population. Lung Cancer. 2013;80:131-7.